Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Node; Prostate × durvalumab × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 79 Lung Neoplasms 45 Carcinoma, Hepatocellular 40 Small Cell Lung Carcinoma 29 Breast Neoplasms 18 Cholangiocarcinoma 16 Biliary Tract Neoplasms 16 Urinary Bladder Neoplasms 15 Neoplasms 13 Liver Neoplasms 13 Triple Negative Breast Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Ovarian Neoplasms 11 Neoplasm Metastasis 11 Pancreatic Neoplasms 10 Carcinoma 10 Stomach Neoplasms 7 Esophageal Neoplasms 7 Colorectal Neoplasms 7 Gallbladder Neoplasms 6 Endometrial Neoplasms 6 Carcinoma, Transitional Cell 6 Prostatic Neoplasms 5 Melanoma 5 Carcinoma, Renal Cell 5 Adenocarcinoma Of Esophagus 5 Adenocarcinoma 5 Non-Muscle Invasive Bladder Neoplasms 4 Neoplasms by Site 4 Mesothelioma 4

Interventions

durvalumab 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03795207 2026-03-31

POSTCARD

Institut Cancerologie de l'Ouest

Phase 2 Active not recruiting

Node; Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡